Beam Therapeutics (BEAM) News Today $21.16 +0.41 (+1.98%) As of 01:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BEAM Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period FY2026 Earnings Forecast for BEAM Issued By Leerink PartnrsJuly 21 at 2:23 AM | americanbankingnews.comWhat is Leerink Partnrs' Forecast for BEAM FY2026 Earnings?July 21 at 2:22 AM | marketbeat.comRadiotherapy of cancer: Researchers enable better cancer treatment using existing medical equipmentJuly 18 at 11:04 PM | msn.comBeam Therapeutics (BEAM) Announces Acquisition of an Early-Stage Life Sciences CompanyJuly 16, 2025 | msn.comBrokerages Set Beam Therapeutics Inc. (NASDAQ:BEAM) Price Target at $48.75July 16, 2025 | americanbankingnews.comBeam Therapeutics (NASDAQ:BEAM) Trading Down 5.6% - Here's What HappenedJuly 15, 2025 | marketbeat.comPeregrine Investment Management Inc. Has $4.38 Million Stake in Beam Therapeutics Inc. (NASDAQ:BEAM)July 13, 2025 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Receives Consensus Recommendation of "Buy" from AnalystsJuly 13, 2025 | marketbeat.comFocused Beam Engraving Gift and RC Hobby Shop now selling RC model vehiclesJuly 12, 2025 | msn.comConcurrent Investment Advisors LLC Takes Position in Beam Therapeutics Inc. (NASDAQ:BEAM)July 11, 2025 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Shares Gap Up - Here's WhyJuly 9, 2025 | marketbeat.comBeam Therapeutics Inc. Research & Ratings - Barron'sJuly 9, 2025 | barrons.comBeam Therapeutics Inc. Advanced Charts | BEAM | Barron'sJuly 9, 2025 | barrons.comD.A. Davidson & CO. Has $1.38 Million Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)July 9, 2025 | marketbeat.comH.C. Wainwright Reiterates a Buy Rating on Beam Therapeutics (BEAM) With an $80 PTJuly 6, 2025 | msn.comInsider Selling: Beam Therapeutics Inc. (NASDAQ:BEAM) Insider Sells 876 Shares of StockJuly 4, 2025 | insidertrades.comBeam Therapeutics’ BEAM-101 Shows Promising Results in Sickle Cell Disease TrialJuly 3, 2025 | msn.comAmy Simon Sells 876 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM) StockJuly 3, 2025 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Trading 5.8% Higher - Here's WhyJuly 2, 2025 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by Sumitomo Mitsui Trust Group Inc.July 1, 2025 | marketbeat.com10 Under-the-Radar Healthcare Stocks With Incredible Growth PotentialJune 28, 2025 | fool.comBeam Therapeutics Inc Ownership - MorningstarJune 25, 2025 | morningstar.comMBeam Therapeutics: Progress Of BEAM-101 Presses Forward With H2 2025 Data ReleasesJune 20, 2025 | seekingalpha.com‘Life just changed.’ How Miami doctors use tech to treat cancer and sickle cellJune 19, 2025 | msn.comBeam Therapeutics Inc. (NASDAQ:BEAM) Given Average Recommendation of "Buy" by AnalystsJune 18, 2025 | marketbeat.comGAMMA Investing LLC Raises Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)June 18, 2025 | marketbeat.comEli Lilly’s $1.3 Billion Bid Sends Verve Therapeutics Stock Soaring. What to Know.June 17, 2025 | msn.comBeam Therapeutics (NASDAQ:BEAM) Shares Gap Up - Should You Buy?June 17, 2025 | marketbeat.comRhumbline Advisers Acquires 14,971 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)June 16, 2025 | marketbeat.comBeam reports positive results from sickle cell disease treatmentJune 13, 2025 | msn.comBeam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 Supporting Differentiated Profile in Sickle Cell Disease (SCD) at European Hematology Association (EHA) 2025 CongressJune 13, 2025 | globenewswire.comCathie Wood’s ARK ETFs adjust holdings, buying GitLab and Beam Therapeutics stockJune 11, 2025 | investing.comEquities Analysts Set Expectations for BEAM FY2026 EarningsJune 11, 2025 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Shares Gap Up - What's Next?June 6, 2025 | marketbeat.comBeam gets FDA orphan drug status for sickle cell disease treatmentJune 3, 2025 | msn.comBeam Therapeutics Gets FDA Orphan Drug Designation for Sickle-Cell Disease TreatmentJune 3, 2025 | marketwatch.comBeam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-101 for the Treatment of Sickle Cell DiseaseJune 3, 2025 | globenewswire.comTwo Sigma Investments LP Increases Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)June 1, 2025 | marketbeat.comBank of America Corp DE Has $3.40 Million Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)June 1, 2025 | marketbeat.comBeam Therapeutics (NASDAQ:BEAM) Trading Down 2.7% - Time to Sell?May 30, 2025 | marketbeat.comFDA Grants Orphan Drug Status to Beam Therapeutics Inc. (BEAM)’ AATD Gene TherapyMay 30, 2025 | msn.comBeam Therapeutics Says FDA Grants Orphan Drug Designation to Lung, Liver TreatmentMay 29, 2025 | marketwatch.comSA analyst upgrades: NVDA, DJT, VKTX, BRK.A, BEAMMay 29, 2025 | msn.comBeam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)May 29, 2025 | uk.finance.yahoo.comBeam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)May 29, 2025 | globenewswire.comBeam Therapeutics: A Cautious Hold On A Base Editing PioneerMay 29, 2025 | seekingalpha.comCandel Shares Rise After FDA Regenerative Medicine Advanced Therapy DesignationMay 29, 2025 | marketwatch.comPolar Asset Management Partners Inc. Has $5.17 Million Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)May 28, 2025 | marketbeat.comSquarepoint Ops LLC Invests $3.85 Million in Beam Therapeutics Inc. (NASDAQ:BEAM)May 28, 2025 | marketbeat.comVoloridge Investment Management LLC Has $10.25 Million Stake in Beam Therapeutics Inc. (NASDAQ:BEAM)May 27, 2025 | marketbeat.com Get Beam Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Email Address BEAM Media Mentions By Week BEAM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BEAM News Sentiment▼-0.280.61▲Average Medical News Sentiment BEAM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BEAM Articles This Week▼77▲BEAM Articles Average Week Get Beam Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRSP News DNLI News EDIT News NTLA News TWST News VCYT News BPMC News ROIV News ELAN News RGC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BEAM) was last updated on 7/21/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beam Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BEAM Stock Alerts